Biogen Inc Stock Price History

BIIB Stock  USD 157.90  0.11  0.07%   
Below is the normalized historical share price chart for Biogen Inc extending back to September 17, 1991. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Biogen stands at 157.90, as last reported on the 24th of November, with the highest price reaching 159.72 and the lowest price hitting 157.28 during the day.
IPO Date
16th of September 1991
200 Day MA
207.8082
50 Day MA
181.8416
Beta
(0.06)
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Biogen Stock, it is important to understand the factors that can impact its price. Biogen Inc secures Sharpe Ratio (or Efficiency) of -0.3, which signifies that the company had a -0.3% return per unit of risk over the last 3 months. Biogen Inc exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Biogen's Standard Deviation of 1.29, risk adjusted performance of (0.22), and Mean Deviation of 0.9972 to double-check the risk estimate we provide.
  
At present, Biogen's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Shares Outstanding is expected to grow to about 283 M, whereas Other Stockholder Equity is projected to grow to (2.5 B). . At present, Biogen's Price To Operating Cash Flows Ratio is projected to decrease significantly based on the last few years of reporting. The current year's Price To Free Cash Flows Ratio is expected to grow to 31.81, whereas Price To Sales Ratio is forecasted to decline to 3.62. Biogen Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.3027

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsBIIB

Estimated Market Risk

 1.29
  actual daily
11
89% of assets are more volatile

Expected Return

 -0.39
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.3
  actual daily
0
Most of other assets perform better
Based on monthly moving average Biogen is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biogen by adding Biogen to a well-diversified portfolio.
Price Book
1.4065
Enterprise Value Ebitda
9.996
Price Sales
2.3949
Shares Float
145.2 M
Wall Street Target Price
251.6969

Biogen Stock Price History Chart

There are several ways to analyze Biogen Stock price data. The simplest method is using a basic Biogen candlestick price chart, which shows Biogen price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceSeptember 4, 2024204.95
Lowest PriceNovember 19, 2024155.43

Biogen November 24, 2024 Stock Price Synopsis

Various analyses of Biogen's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Biogen Stock. It can be used to describe the percentage change in the price of Biogen from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Biogen Stock.
Biogen Price Rate Of Daily Change 1.00 
Biogen Price Daily Balance Of Power(0.05)
Biogen Price Action Indicator(0.65)

Biogen November 24, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Biogen Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Biogen intraday prices and daily technical indicators to check the level of noise trading in Biogen Stock and then apply it to test your longer-term investment strategies against Biogen.

Biogen Stock Price History Data

The price series of Biogen for the period between Mon, Aug 26, 2024 and Sun, Nov 24, 2024 has a statistical range of 49.57 with a coefficient of variation of 7.57. The prices are distributed with arithmetic mean of 186.78. The median price for the last 90 days is 189.0. The company had 3:1 stock split on 18th of January 2001.
OpenHighLowCloseVolume
11/24/2024
 158.10  159.72  157.28  157.90 
11/22/2024 158.10  159.72  157.28  157.90  1,701,959 
11/21/2024 156.96  159.10  154.75  158.01  1,736,306 
11/20/2024 155.03  156.18  153.63  156.00  1,560,602 
11/19/2024 157.31  157.90  155.28  155.43  1,259,040 
11/18/2024 158.19  160.11  157.40  157.94  1,609,061 
11/15/2024 165.46  166.34  159.60  159.99  1,903,479 
11/14/2024 165.00  175.86  163.35  164.89  3,201,611 
11/13/2024 167.74  168.98  165.53  165.79  1,393,559 
11/12/2024 171.36  171.61  167.71  168.28  1,324,495 
11/11/2024 173.92  173.92  171.12  172.03  1,415,455 
11/08/2024 173.58  175.19  171.57  173.04  1,581,624 
11/07/2024 175.50  176.95  172.95  173.92  1,296,222 
11/06/2024 177.00  179.20  173.66  174.40  1,816,334 
11/05/2024 172.47  177.25  170.72  176.93  2,464,991 
11/04/2024 173.50  174.85  170.71  173.52  2,494,358 
11/01/2024 173.65  175.99  173.15  173.79  1,431,217 
10/31/2024 178.11  179.48  173.88  174.00  1,738,476 
10/30/2024 184.63  185.00  177.96  181.18  1,632,228 
10/29/2024 184.82  187.28  183.19  183.47  1,326,854 
10/28/2024 182.48  185.60  181.73  185.01  1,771,693 
10/25/2024 185.70  187.58  181.25  181.69  1,714,084 
10/24/2024 184.79  185.72  183.28  183.86  1,022,306 
10/23/2024 184.88  185.82  182.11  182.98  973,595 
10/22/2024 183.81  186.54  182.80  185.90  829,657 
10/21/2024 188.22  190.25  184.02  184.65  940,824 
10/18/2024 188.22  191.19  188.06  190.16  923,306 
10/17/2024 188.55  190.19  187.71  189.55  728,765 
10/16/2024 191.68  192.16  188.90  189.00  800,673 
10/15/2024 191.87  194.13  190.67  191.55  1,429,216 
10/14/2024 188.50  191.96  186.61  191.56  1,273,907 
10/11/2024 189.00  189.43  186.91  188.38  1,218,870 
10/10/2024 184.56  188.88  184.30  188.59  1,323,035 
10/09/2024 182.46  185.79  181.31  185.76  936,392 
10/08/2024 182.73  183.43  181.31  182.30  1,175,340 
10/07/2024 184.76  185.91  182.48  183.34  983,302 
10/04/2024 186.68  186.80  183.82  185.68  1,106,526 
10/03/2024 187.21  187.89  183.56  184.78  2,036,939 
10/02/2024 190.11  191.86  188.05  188.74  1,228,731 
10/01/2024 194.61  195.00  190.27  190.80  2,235,646 
09/30/2024 193.36  194.45  192.28  193.84  941,259 
09/27/2024 194.49  197.70  193.98  194.67  682,779 
09/26/2024 191.17  193.73  190.50  193.60  817,412 
09/25/2024 193.84  194.56  188.78  189.07  1,540,638 
09/24/2024 199.99  199.99  193.54  194.12  1,148,823 
09/23/2024 199.20  199.20  195.67  195.81  1,229,375 
09/20/2024 200.01  200.37  196.97  199.36  3,807,347 
09/19/2024 200.57  204.18  200.11  201.44  991,157 
09/18/2024 198.13  199.78  196.87  197.59  659,193 
09/17/2024 199.83  202.79  197.09  198.21  923,897 
09/16/2024 196.89  199.74  194.75  199.58  938,473 
09/13/2024 197.66  197.66  192.25  195.63  1,088,873 
09/12/2024 199.05  199.26  194.90  197.89  826,270 
09/11/2024 199.28  199.28  196.02  199.09  723,482 
09/10/2024 199.49  201.19  197.82  200.64  523,824 
09/09/2024 200.44  201.06  198.11  199.27  831,719 
09/06/2024 202.53  203.24  198.55  200.81  833,140 
09/05/2024 205.19  205.19  198.19  201.80  1,093,662 
09/04/2024 205.72  206.50  203.53  204.95  749,227 
09/03/2024 204.22  206.70  203.51  204.84  870,916 
08/30/2024 205.82  205.88  202.87  204.76  878,984 

About Biogen Stock history

Biogen investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Biogen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Biogen Inc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Biogen stock prices may prove useful in developing a viable investing in Biogen
Last ReportedProjected for Next Year
Common Stock Shares Outstanding145.6 M283 M
Net Income Applicable To Common Shares3.5 BB

Biogen Quarterly Net Working Capital

1.41 Billion

Biogen Stock Technical Analysis

Biogen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Biogen technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Biogen trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Content Syndication Now

   

Content Syndication

Quickly integrate customizable finance content to your own investment portal
All  Next Launch Module

Biogen Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Biogen's price direction in advance. Along with the technical and fundamental analysis of Biogen Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Biogen to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Biogen Stock analysis

When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Money Managers
Screen money managers from public funds and ETFs managed around the world
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios